93 related articles for article (PubMed ID: 22309258)
1. Sequence evolution and escape from specific immune pressure of an HIV-1 Rev epitope with extensive sequence similarity to human nucleolar protein 6.
Allard SD; de Goede AL; De Keersmaecker B; Heirman C; Lacor P; Osterhaus AD; Demanet C; Thielemans K; Gruters RA; Aerts JL
Tissue Antigens; 2012 Mar; 79(3):174-85. PubMed ID: 22309258
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 evolution in patients undergoing immunotherapy with Tat, Rev, and Nef expressing dendritic cells followed by treatment interruption.
de Goede AL; van Deutekom HW; Vrancken B; Schutten M; Allard SD; van Baalen CA; Osterhaus AD; Thielemans K; Aerts JL; Keşmir C; Lemey P; Gruters RA
AIDS; 2013 Nov; 27(17):2679-89. PubMed ID: 24149085
[TBL] [Abstract][Full Text] [Related]
3. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
Allen TM; Altfeld M; Yu XG; O'Sullivan KM; Lichterfeld M; Le Gall S; John M; Mothe BR; Lee PK; Kalife ET; Cohen DE; Freedberg KA; Strick DA; Johnston MN; Sette A; Rosenberg ES; Mallal SA; Goulder PJ; Brander C; Walker BD
J Virol; 2004 Jul; 78(13):7069-78. PubMed ID: 15194783
[TBL] [Abstract][Full Text] [Related]
4. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
[TBL] [Abstract][Full Text] [Related]
5. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
[TBL] [Abstract][Full Text] [Related]
6. Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals.
Thorn M; Tang S; Therrien D; Kløverpris H; Vinner L; Kronborg G; Gerstoft J; Corbet S; Fomsgaard A
APMIS; 2007 Jun; 115(6):757-68. PubMed ID: 17550385
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of HIV-1 CD8+ T cell escape variants with impaired fitness.
Sanchez-Merino V; Farrow MA; Brewster F; Somasundaran M; Luzuriaga K
J Infect Dis; 2008 Jan; 197(2):300-8. PubMed ID: 18177249
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption.
Harrer E; Bäuerle M; Ferstl B; Chaplin P; Petzold B; Mateo L; Handley A; Tzatzaris M; Vollmar J; Bergmann S; Rittmaier M; Eismann K; Müller S; Kalden JR; Spriewald B; Willbold D; Harrer T
Antivir Ther; 2005; 10(2):285-300. PubMed ID: 15865223
[TBL] [Abstract][Full Text] [Related]
9. Highly restricted T-cell receptor repertoire in the CD8+ T-cell response against an HIV-1 epitope with a stereotypic amino acid substitution.
Miyazaki E; Kawana-Tachikawa A; Tomizawa M; Nunoya J; Odawara T; Fujii T; Shi Y; Gao GF; Iwamoto A
AIDS; 2009 Mar; 23(6):651-60. PubMed ID: 19279440
[TBL] [Abstract][Full Text] [Related]
10. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC
J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973
[TBL] [Abstract][Full Text] [Related]
11. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
Altfeld M; Allen TM; Kalife ET; Frahm N; Addo MM; Mothe BR; Rathod A; Reyor LL; Harlow J; Yu XG; Perkins B; Robinson LK; Sidney J; Alter G; Lichterfeld M; Sette A; Rosenberg ES; Goulder PJ; Brander C; Walker BD
J Virol; 2005 Apr; 79(8):5000-5. PubMed ID: 15795285
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
Gillespie GM; Pinheiro S; Sayeid-Al-Jamee M; Alabi A; Kaye S; Sabally S; Sarge-Njie R; Njai H; Joof K; Jaye A; Whittle H; Rowland-Jones S; Dorrell L
Eur J Immunol; 2005 May; 35(5):1445-53. PubMed ID: 15832290
[TBL] [Abstract][Full Text] [Related]
13. Selection of escape mutation by Pol154-162-specific cytotoxic T cells among chronically HIV-1-infected HLA-B*5401-positive individuals.
Hashimoto M; Kitano M; Honda K; Koizumi H; Dohki S; Oka S; Takiguchi M
Hum Immunol; 2010 Feb; 71(2):123-7. PubMed ID: 19891998
[TBL] [Abstract][Full Text] [Related]
14. Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: constraints on immune escape associated with targeting a sequence essential for viral replication.
Wagner R; Leschonsky B; Harrer E; Paulus C; Weber C; Walker BD; Buchbinder S; Wolf H; Kalden JR; Harrer T
J Immunol; 1999 Mar; 162(6):3727-34. PubMed ID: 10092836
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.
Price DA; O'callaghan CA; Whelan JA; Easterbrook PJ; Phillips RE
Clin Sci (Lond); 1999 Dec; 97(6):707-18. PubMed ID: 10585898
[TBL] [Abstract][Full Text] [Related]
16. Helper and cytotoxic T cell responses of HIV type 1-infected individuals to synthetic peptides of HIV type 1 Rev.
Blazevic V; Ranki A; Krohn KJ
AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1335-42. PubMed ID: 8573390
[TBL] [Abstract][Full Text] [Related]
17. Immunoescape of HIV-1 in Env-EL9 CD8 + T cell response restricted by HLA-B*14:02 in a Non progressor who lost twenty-seven years of HIV-1 control.
Moyano A; Blanch-Lombarte O; Tarancon-Diez L; Pedreño-Lopez N; Arenas M; Alvaro T; Casado C; Olivares I; Vera M; Rodriguez C; Del Romero J; López-Galíndez C; Ruiz-Mateos E; Prado JG; Pernas M
Retrovirology; 2022 Mar; 19(1):6. PubMed ID: 35346235
[TBL] [Abstract][Full Text] [Related]
18. Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome.
Song H; Pavlicek JW; Cai F; Bhattacharya T; Li H; Iyer SS; Bar KJ; Decker JM; Goonetilleke N; Liu MK; Berg A; Hora B; Drinker MS; Eudailey J; Pickeral J; Moody MA; Ferrari G; McMichael A; Perelson AS; Shaw GM; Hahn BH; Haynes BF; Gao F
Retrovirology; 2012 Oct; 9():89. PubMed ID: 23110705
[TBL] [Abstract][Full Text] [Related]
19. [Peptide mapping of H-2d restricted T-cell epitope against six antigens of HIV-1 subtype B'/C by ELISPOT assay].
Qi XR; Gao YY; Lu RJ; Deng Y; Meng X; Tan WJ; Ruan L
Bing Du Xue Bao; 2011 Jan; 27(1):34-43. PubMed ID: 21462504
[TBL] [Abstract][Full Text] [Related]
20. B-cell epitopes in HIV-1 Tat and Rev proteins colocalize with T-cell epitopes and with functional domains.
Tähtinen M; Ranki A; Valle SL; Ovod V; Krohn K
Biomed Pharmacother; 1997; 51(10):480-7. PubMed ID: 9863510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
